Literature DB >> 24733654

Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass.

David J Bonda1, Xinglong Wang, Hyoung-Gon Lee, Mark A Smith, George Perry, Xiongwei Zhu.   

Abstract

Considerable debate and controversy surround the cause(s) of Alzheimer's disease (AD). To date, several theories have gained notoriety, however none is universally accepted. In this review, we provide evidence for the oxidative stress-induced AD cascade that posits aged mitochondria as the critical origin of neurodegeneration in AD.

Entities:  

Mesh：

Year:  2014        PMID： 24733654      PMCID： PMC4097013          DOI： 10.1007/s12264-013-1424-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.203


  109 in total

Review 1.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

Authors:  D A Butterfield; J Drake; C Pocernich; A Castegna
Journal:  Trends Mol Med       Date:  2001-12       Impact factor: 11.951

Review 2.  Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 3.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

4.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

5.  The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

Review 6.  Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.

Authors:  Jian-Zhi Wang; Yi-Yuan Xia; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Neurons may live for decades with neurofibrillary tangles.

Authors:  R Morsch; W Simon; P D Coleman
Journal:  J Neuropathol Exp Neurol       Date:  1999-02       Impact factor: 3.685

8.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

9.  Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.

Authors:  Sandra L Siedlak; Gemma Casadesus; Kate M Webber; Miguel A Pappolla; Craig S Atwood; Mark A Smith; George Perry
Journal:  Free Radic Res       Date:  2009-02

10.  Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.

Authors:  Gjumrakch Aliev; Jiankang Liu; Justin C Shenk; Kathryn Fischbach; Gerardo J Pacheco; Shu G Chen; Mark E Obrenovich; Walter F Ward; Arlan G Richardson; Mark A Smith; Eldar Gasimov; George Perry; Bruce N Ames
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310
View more
  35 in total

Review 1.  Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.

Authors:  Judit M Perez Ortiz; Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

2.  Transcriptome profiling of expression changes during neuronal death by RNA-Seq.

Authors:  Dharmendra Sharma; Min Soo Kim; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2014-09-25

3.  Alzheimer's disease: from molecule to clinic.

Authors:  Jian-Zhi Wang
Journal:  Neurosci Bull       Date:  2014-04       Impact factor: 5.203

4.  Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET.

Authors:  G C Chiang; X Mao; G Kang; E Chang; S Pandya; S Vallabhajosula; R Isaacson; L D Ravdin; D C Shungu
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-24       Impact factor: 3.825

Review 5.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 6.  Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.

Authors:  Suzanne M de la Monte
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

7.  Acute exposure to a Mn/Zn ethylene-bis-dithiocarbamate fungicide leads to mitochondrial dysfunction and increased reactive oxygen species production in Caenorhabditis elegans.

Authors:  Callie E Todt; Denise C Bailey; Aireal S Pressley; Sarah E Orfield; Rachel D Denney; Isaac B Snapp; Rekek Negga; Andrew C Bailey; Kara M Montgomery; Wendy L Traynor; Vanessa A Fitsanakis
Journal:  Neurotoxicology       Date:  2016-09-20       Impact factor: 4.294

Review 8.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

9.  Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease.

Authors:  P Hemachandra Reddy; Maria Manczak; Ramesh Kandimalla
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

Review 10.  Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder.

Authors:  Viplav Kshirsagar; Chetan Thingore; Archana Juvekar
Journal:  Metab Brain Dis       Date:  2020-09-28       Impact factor: 3.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.